Evidence map›Paper›PMID 40235608›Full record

ReviewFocus (American Psychiatric Publishing)2025

Targeted Research and Treatment Implications in Women With Depression.

Marie E Gaine, Kathleen M Jagodnik, Ritika Baweja, William V Bobo, Erin C McGlade, Sandra J Weiss, Marissa L Beal, Sharon Dekel, Aysegul Ozerdem

Abstract readReview
In one paragraph

Review in Focus (American Psychiatric Publishing), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marie E GaineDepartment of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, and Iowa Neuroscience Institute, University of Iowa, Iowa City (Gaine); Department of Psychiatry, Harvard Medical School and Massachusetts General Hospital, Boston (Jagodnik, Dekel); Department of Psychiatry and Behavioral Health and Department of Obstetrics and Gynecology, College of Medicine, Pennsylvania State University, Hershey (Baweja); Department of Behavioral Science and Social Medicine, College of Medicine, Florida State University, Tallahassee (Bobo); Department of Psychiatry, Huntsman Mental Health Institute, School of Medicine, University of Utah, and Department of Veterans Affairs, Rocky Mountain Mental Illness Research, Education, and Clinical Center, Salt Lake City (McGlade); Department of Community Health Systems, University of California, San Francisco (Weiss); Department of Psychiatry and Behavioral Health, Pennsylvania State University College of Medicine, Hershey (Beal); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota (Ozerdem).
Kathleen M JagodnikDepartment of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, and Iowa Neuroscience Institute, University of Iowa, Iowa City (Gaine); Department of Psychiatry, Harvard Medical School and Massachusetts General Hospital, Boston (Jagodnik, Dekel); Department of Psychiatry and Behavioral Health and Department of Obstetrics and Gynecology, College of Medicine, Pennsylvania State University, Hershey (Baweja); Department of Behavioral Science and Social Medicine, College of Medicine, Florida State University, Tallahassee (Bobo); Department of Psychiatry, Huntsman Mental Health Institute, School of Medicine, University of Utah, and Department of Veterans Affairs, Rocky Mountain Mental Illness Research, Education, and Clinical Center, Salt Lake City (McGlade); Department of Community Health Systems, University of California, San Francisco (Weiss); Department of Psychiatry and Behavioral Health, Pennsylvania State University College of Medicine, Hershey (Beal); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota (Ozerdem).
Ritika BawejaDepartment of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, and Iowa Neuroscience Institute, University of Iowa, Iowa City (Gaine); Department of Psychiatry, Harvard Medical School and Massachusetts General Hospital, Boston (Jagodnik, Dekel); Department of Psychiatry and Behavioral Health and Department of Obstetrics and Gynecology, College of Medicine, Pennsylvania State University, Hershey (Baweja); Department of Behavioral Science and Social Medicine, College of Medicine, Florida State University, Tallahassee (Bobo); Department of Psychiatry, Huntsman Mental Health Institute, School of Medicine, University of Utah, and Department of Veterans Affairs, Rocky Mountain Mental Illness Research, Education, and Clinical Center, Salt Lake City (McGlade); Department of Community Health Systems, University of California, San Francisco (Weiss); Department of Psychiatry and Behavioral Health, Pennsylvania State University College of Medicine, Hershey (Beal); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota (Ozerdem).
William V BoboDepartment of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, and Iowa Neuroscience Institute, University of Iowa, Iowa City (Gaine); Department of Psychiatry, Harvard Medical School and Massachusetts General Hospital, Boston (Jagodnik, Dekel); Department of Psychiatry and Behavioral Health and Department of Obstetrics and Gynecology, College of Medicine, Pennsylvania State University, Hershey (Baweja); Department of Behavioral Science and Social Medicine, College of Medicine, Florida State University, Tallahassee (Bobo); Department of Psychiatry, Huntsman Mental Health Institute, School of Medicine, University of Utah, and Department of Veterans Affairs, Rocky Mountain Mental Illness Research, Education, and Clinical Center, Salt Lake City (McGlade); Department of Community Health Systems, University of California, San Francisco (Weiss); Department of Psychiatry and Behavioral Health, Pennsylvania State University College of Medicine, Hershey (Beal); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota (Ozerdem).
Erin C McGladeDepartment of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, and Iowa Neuroscience Institute, University of Iowa, Iowa City (Gaine); Department of Psychiatry, Harvard Medical School and Massachusetts General Hospital, Boston (Jagodnik, Dekel); Department of Psychiatry and Behavioral Health and Department of Obstetrics and Gynecology, College of Medicine, Pennsylvania State University, Hershey (Baweja); Department of Behavioral Science and Social Medicine, College of Medicine, Florida State University, Tallahassee (Bobo); Department of Psychiatry, Huntsman Mental Health Institute, School of Medicine, University of Utah, and Department of Veterans Affairs, Rocky Mountain Mental Illness Research, Education, and Clinical Center, Salt Lake City (McGlade); Department of Community Health Systems, University of California, San Francisco (Weiss); Department of Psychiatry and Behavioral Health, Pennsylvania State University College of Medicine, Hershey (Beal); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota (Ozerdem).
Sandra J WeissDepartment of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, and Iowa Neuroscience Institute, University of Iowa, Iowa City (Gaine); Department of Psychiatry, Harvard Medical School and Massachusetts General Hospital, Boston (Jagodnik, Dekel); Department of Psychiatry and Behavioral Health and Department of Obstetrics and Gynecology, College of Medicine, Pennsylvania State University, Hershey (Baweja); Department of Behavioral Science and Social Medicine, College of Medicine, Florida State University, Tallahassee (Bobo); Department of Psychiatry, Huntsman Mental Health Institute, School of Medicine, University of Utah, and Department of Veterans Affairs, Rocky Mountain Mental Illness Research, Education, and Clinical Center, Salt Lake City (McGlade); Department of Community Health Systems, University of California, San Francisco (Weiss); Department of Psychiatry and Behavioral Health, Pennsylvania State University College of Medicine, Hershey (Beal); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota (Ozerdem).
Marissa L BealDepartment of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, and Iowa Neuroscience Institute, University of Iowa, Iowa City (Gaine); Department of Psychiatry, Harvard Medical School and Massachusetts General Hospital, Boston (Jagodnik, Dekel); Department of Psychiatry and Behavioral Health and Department of Obstetrics and Gynecology, College of Medicine, Pennsylvania State University, Hershey (Baweja); Department of Behavioral Science and Social Medicine, College of Medicine, Florida State University, Tallahassee (Bobo); Department of Psychiatry, Huntsman Mental Health Institute, School of Medicine, University of Utah, and Department of Veterans Affairs, Rocky Mountain Mental Illness Research, Education, and Clinical Center, Salt Lake City (McGlade); Department of Community Health Systems, University of California, San Francisco (Weiss); Department of Psychiatry and Behavioral Health, Pennsylvania State University College of Medicine, Hershey (Beal); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota (Ozerdem).
Sharon DekelDepartment of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, and Iowa Neuroscience Institute, University of Iowa, Iowa City (Gaine); Department of Psychiatry, Harvard Medical School and Massachusetts General Hospital, Boston (Jagodnik, Dekel); Department of Psychiatry and Behavioral Health and Department of Obstetrics and Gynecology, College of Medicine, Pennsylvania State University, Hershey (Baweja); Department of Behavioral Science and Social Medicine, College of Medicine, Florida State University, Tallahassee (Bobo); Department of Psychiatry, Huntsman Mental Health Institute, School of Medicine, University of Utah, and Department of Veterans Affairs, Rocky Mountain Mental Illness Research, Education, and Clinical Center, Salt Lake City (McGlade); Department of Community Health Systems, University of California, San Francisco (Weiss); Department of Psychiatry and Behavioral Health, Pennsylvania State University College of Medicine, Hershey (Beal); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota (Ozerdem).
Aysegul OzerdemDepartment of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, and Iowa Neuroscience Institute, University of Iowa, Iowa City (Gaine); Department of Psychiatry, Harvard Medical School and Massachusetts General Hospital, Boston (Jagodnik, Dekel); Department of Psychiatry and Behavioral Health and Department of Obstetrics and Gynecology, College of Medicine, Pennsylvania State University, Hershey (Baweja); Department of Behavioral Science and Social Medicine, College of Medicine, Florida State University, Tallahassee (Bobo); Department of Psychiatry, Huntsman Mental Health Institute, School of Medicine, University of Utah, and Department of Veterans Affairs, Rocky Mountain Mental Illness Research, Education, and Clinical Center, Salt Lake City (McGlade); Department of Community Health Systems, University of California, San Francisco (Weiss); Department of Psychiatry and Behavioral Health, Pennsylvania State University College of Medicine, Hershey (Beal); Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota (Ozerdem).

Funding

Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI HANS-JOACHIM LEHMLER · 1990 to 2026
$40.5M
University of Iowa Hawkeye Intellectual and Developmental Disabilities Research Center (Hawk-IDDRC)P50HD103556 · NICHD · UNIVERSITY OF IOWA · PI EDWIN TED G. ABEL, Lane Strathearn · 2021 to 2026
$8.5M
NICHD NIH HHS P50 HD103556NIEHS NIH HHS P30 ES005605
6 · The paper itself

Abstract

Women with a history of traumatic experience, particularly adversity encountered during childhood, have an increased risk of developing depression. The authors review the biological mechanisms associating trauma with depression, including the role of the hypothalamic-pituitary-adrenal axis. Additionally, the psychosocial and cultural considerations associating traumatic experience with depression are discussed, and current gaps in knowledge about biological mechanisms, psychosocial factors, and cultural aspects relating trauma to depression that remain to be addressed are described. Women with a history of trauma are also at increased risk for engaging in suicidal behaviors, including suicidal ideation and attempts. Increased suicidality in women with a history of trauma has been observed in various populations, including among victims of intimate partner violence, female veterans, refugees, and individuals who identify as lesbian, gay, bisexual, transgender, queer or questioning, or other. Although associations between trauma and suicidality have been well documented, limited research has examined the impact of age or reproductive stage, an important area for future research. A wide range of biological, psychosocial, and cultural factors that can increase the risk for suicidality across the lifespan in women are described, and how they may be included when completing clinical assessments for women is highlighted. Machine learning, and its use in risk and outcome prediction of depression in women across reproductive stages toward individualized psychiatric services, is introduced, with future directions reviewed.

Indexed as

biologydepressionDepressive Disordersmachine learningpsycho-socialsuicidalitytraumaWomen

Identifiers

PMID40235608
PMCPMC11995897

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.